National Research Corporation NR1A.SG Stock
National Research Corporation Price Chart
National Research Corporation NR1A.SG Financial and Trading Overview
National Research Corporation stock price | 31.8 EUR |
Previous Close | 40.2 EUR |
Open | 40 EUR |
Bid | 40 EUR x N/A |
Ask | 42 EUR x N/A |
Day's Range | 40 - 40 EUR |
52 Week Range | 32.2 - 43 EUR |
Volume | 0 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.01B EUR |
Beta (5Y Monthly) | 0.519718 |
PE Ratio (TTM) | 35.714287 |
EPS (TTM) | 1.16 EUR |
Forward Dividend & Yield | 0.58 (1.41%) |
Ex-Dividend Date | June 29, 2023 |
1y Target Est | N/A |
NR1A.SG Valuation Measures
Enterprise Value | 849.1M EUR |
Trailing P/E | 35.714287 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.776925 |
Price/Book (mrq) | 13.170893 |
Enterprise Value/Revenue | 5.676 |
Enterprise Value/EBITDA | 17.252 |
Trading Information
National Research Corporation Stock Price History
Beta (5Y Monthly) | 0.519718 |
52-Week Change | 19.52% |
S&P500 52-Week Change | 20.43% |
52 Week High | 43 EUR |
52 Week Low | 32.2 EUR |
50-Day Moving Average | 39.28 EUR |
200-Day Moving Average | 38.4 EUR |
NR1A.SG Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 24.61M |
Float | 14.38M |
Short Ratio | N/A |
% Held by Insiders | 42.09% |
% Held by Institutions | 47.70% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.72 |
Trailing Annual Dividend Yield | 1.79% |
5 Year Average Dividend Yield | 136.00% |
Payout Ratio | 0.595 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 20.20% |
Operating Margin (ttm) | 29.32% |
Gross Margin | 62.19% |
EBITDA Margin | 32.89% |
Management Effectiveness
Return on Assets (ttm) | 19.07% |
Return on Equity (ttm) | 38.71% |
Income Statement
Revenue (ttm) | 149.6M EUR |
Revenue Per Share (ttm) | 6.04 EUR |
Quarterly Revenue Growth (yoy) | -5.099% |
Gross Profit (ttm) | 94.52M EUR |
EBITDA | 49.22M EUR |
Net Income Avi to Common (ttm) | 30.21M EUR |
Diluted EPS (ttm) | 1.12 |
Quarterly Earnings Growth (yoy) | -18.39% |
Balance Sheet
Total Cash (mrq) | 23.72M EUR |
Total Cash Per Share (mrq) | 0.97 EUR |
Total Debt (mrq) | 21.76M EUR |
Total Debt/Equity (mrq) | 29.14 EUR |
Current Ratio (mrq) | 1.251 |
Book Value Per Share (mrq) | 3.037 |
Cash Flow Statement
Operating Cash Flow (ttm) | 35.73M EUR |
Levered Free Cash Flow (ttm) | 17.66M EUR |
Profile of National Research Corporation
Country | Germany |
State | NE |
City | Lincoln |
Address | 1245 Q Street |
ZIP | 68508 |
Phone | 402 475 2525 |
Website | https://nrchealth.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 491 |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Q&A For National Research Corporation Stock
What is a current NR1A.SG stock price?
National Research Corporation NR1A.SG stock price today per share is 31.8 EUR.
How to purchase National Research Corporation stock?
You can buy NR1A.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for National Research Corporation?
The stock symbol or ticker of National Research Corporation is NR1A.SG.
Which industry does the National Research Corporation company belong to?
The National Research Corporation industry is Health Information Services.
How many shares does National Research Corporation have in circulation?
The max supply of National Research Corporation shares is 23.86M.
What is National Research Corporation Price to Earnings Ratio (PE Ratio)?
National Research Corporation PE Ratio is 27.41379400 now.
What was National Research Corporation earnings per share over the trailing 12 months (TTM)?
National Research Corporation EPS is 1.16 EUR over the trailing 12 months.
Which sector does the National Research Corporation company belong to?
The National Research Corporation sector is Healthcare.